Co-Chairs

Bruce A. Goldberger, PhD, DABFT
Associate Professor and
Director of Toxicology
Departments of Pathology and Psychiatry
College of Medicine, University of Florida
Rocky Point Labs
Gainesville, FL
Mark W. Parrino, MPA
President
American Association for the Treatment of Opioid Dependence (AATOD)
New York, NY
Seddon R. Savage, MD, FASAM
Pain Consultant, Manchester VAMC
Project Director
New Hampshire ReMOTE Project
Bradford, NH
Associate Professor of Anesthesiology
Adjunct Faculty, Dartmouth Medical School

Participants

(alphabetically)

Gavin Bart, MD
Director of Clinical Research
Laboratory of the Biology of Addictive Diseases
The Rockefeller University
New York, NY

Lawrence S. Brown, Jr., MD, MPH, FASAM
President, American Society of Addiction Medicine (ASAM)
Senior Vice President
Addiction Research and Treatment Corporation
Brooklyn, NY

Yale H. Caplan, PhD
Director
National Scientific Services
Baltimore, MD

Jennifer Collier, JD
Director of National Policy and State Strategy
Legal Action Center
Washington, DC

Edward J. Cone, PhD
Pinney Associates
Bethesda, MD

Daniel S. Connolly
Director, Giuliani Partners, LLC
New York, NY

Fiona J. Couper, PhD
Chief Toxicologist
Office of the Chief Medical Examiner
Government of the District of Columbia
Washington, DC

Ed Covington, MD
Director
Chronic Pain Rehabilitation Program
Cleveland Clinic Foundation
Cleveland, OH

Gregory G. Davis, MD, MSPH
Associate Professor of Pathology, Forensic Division
University of Alabama at Birmingham
Birmingham, AL

Ken DeCerchio, MSW, CAP
Director of Substance Abuse
Department of Children and Families
Tallahassee, FL

Danna E. Droz, JD
Consultant
Frankfort, KY

Aaron M. Gilson, PhD
Assistant Director
Pain and Policy Studies Group
University of Wisconsin-Madison
Madison, WI

Ann Marie Gordon, MS
Laboratory Manager
Washington State Toxicology Laboratory
Washington State Patrol
Seattle, WA

Douglas Gourlay, MD, FRCP, FASAM
Medical Consultant
Center for Addiction and Mental Health
Toronto, Ontario; Canada

Randy L. Hanzlick, MD
Chief Medical Examiner, Fulton County, Georgia
Associate Professor, Emory School of Medicine
Atlanta, GA

Robert Heimer, PhD
Associate Professor of Epidemiology and Public Health and of Pharmacology
Yale University School of Medicine
New Haven, CT

Howard A. Heit, MD, FACP, FASAM
Assistant Clinical Professor, Georgetown University
Liaison Committee of Pain and Addiction
Fairfax, VA

Jack E. Henningfield, PhD
Vice President, Research and Health Policy
Pinney Associates
Bethesda, MD

John D. Howard, MD
Chief Medical Examiner, Pierce County Medical Examiner's Office
National Association of Medical Examiners
Tacoma, WA

Jerome H. Jaffe, MD
Clinical Professor of Psychiatry
University of Maryland School of Medicine
Baltimore, MD

Amanda Jenkins, PhD
Chief Toxicologist
The Office of the Cuyahoga County Coroner
Cleveland, OH

Herman Joseph, PhD
Social Research Scientist
National Alliance of Methadone Advocates
New York, NY

Paul T. Kersten
General Manager, Sales and Marketing
Roxane Laboratories, Inc.
Bedford, OH

Mori J. Krantz, MD
Associate Professor of Medicine and Cardiology
Denver Health
Denver, CO

Mary Jeanne Kreek, MD
Professor, Head of Laboratory, and Senior Physician
The Laboratory of the Biology of Addictive Diseases
The Rockefeller University
New York, NY

Bridget Martell, MD, MA
Medical Director
Melrose-On-Track Clinic
Albert Einstein College of Medicine
Bronx, NY

Jane C. Maxwell, PhD
Research Scientist
Gulf Coast Addiction Technology Transfer Center
The University of Texas at Austin
Austin, TX

Elinore McCance-Katz, MD, PhD
American Academy of Addiction Psychiatry
Prairie Village, KS
Professor of Psychiatry and Chair, Addiction Psychiatry
Medical College of Virginia
Richmond, VA

Michael Neely, MBA
Senior Product Manager, Addiction Therapy
Tycohealthcare, Mallinckrodt, Inc.
Hazelwood, MO

Raymond I. Pora
Sales/Marketing
VistaPharm, Inc.
Frankfort, IL

Catharine (Kay) Sanford, MSPH
Public Health Epidemiologist
Injury and Violence Prevention
Department of Health and Human Services
State of North Carolina
Raleigh, NC

Michael J. Schobelock, PharmD
Associate Director
Medical Affairs Department
Roxane Laboratories, Inc.
Columbus, OH

Mark J. Shuman, MD, MS
Associate Medical Examiner
Miami-Dade County Medical Examiner Department
Miami, FL

Marcella H. Sorg, PhD, RN
Research Associate
Margaret Chase Smith Center for Public Policy
University of Maine
Orono, ME

Flo Stein, MPH
Chief, Community Policy Management
Division of Mental Health, Developmental Disabilities, and Substance Abuse Services
North Carolina Department of Health and Human Services
Raleigh, NC

Barry Stimmel, MD
Editor, Journal of Addictive Disease
Dean, Graduate Medical Education
Mount Sinai School of Medicine
New York, NY

Royce Watkins
Chairman and Chief Executive Officer
Cebert Pharmaceuticals, Inc.
Birmingham, A

Federal Partner Participants

(alphabetically)

Dan Budnitz, MD, MPH
EIS Officer
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention
Atlanta, GA

Silvia Calderon, PhD
Team Leader and Interdisciplinary Scientist
Controlled Substance Staff
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

H. Westley Clark, MD, JD, MPH, CAS, FASAM
Director
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

Elizabeth Crane, PhD, MPH
Service Fellow
Drug Abuse Warning Network
Office of Applied Studies
Substance Abuse and Mental Health Services Administration
Rockville, MD

Denise Curry, MA, JD
Liaison Unit Chief
Office of Diversion Control
Drug Enforcement Administration
Arlington, VA

Gretchen Feussner
Pharmacologist
Drug and Chemical Evaluation Section
Office of Diversion Control
Drug Enforcement Administration
Washington, DC

Lois A. Fingerhut, MA
Special Assistant for Injury Epidemiology
National Center for Health Statistics
Centers for Disease Control and Prevention
Hyattsville, MD

Angel Gonzalez, MD
Medical Officer
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

Laura A. Governale, PharmD
Drug Utilization Specialist
Office of Drug Safety
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

Melvyn Robert Haas, MD
Associate Director for Medical Affairs
Center for Mental Health Services
Substance Abuse and Mental Health Services Administration
Rockville, MD

June E. Howard
Chief, Targeting and Analysis Unit, Drug Operations Section
Office of Diversion Control
Drug Enforcement Administration

James R. Hunter, RPh, MPH
Senior Program Manager
Controlled Substance Staff
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

Kirk E. James, MD
Special Expert
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

T. Stephen Jones, MD
Associate Director for Prevention of Bloodborne Infections
Centers for Disease Control and Prevention
Atlanta, GA

Deborah B. Leiderman, MD
Director
Controlled Substance Staff
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

Robert Lubran, MS, MPA
Director
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

Moira O'Brien, MPhil
Program Director, Research on Emerging and Current Trends
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse
National Institutes of Health
Bethesda, MD

Rita Ouellet-Hellstrom, PhD
Epidemiologist
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

Martin L. Pollock, PharmD
Safety Evaluator
Office of Drug Safety
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

Robert A. Rappaport, MD
Acting Director
Division of Anesthetic, Critical Care and Addiction Drug Products
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

Nicholas P. Reuter, MPH
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

Barbara T. Roberts, PhD
Associate Deputy Director
Office for Demand Reduction
White House Office of National Drug Control Policy
Washington, DC

Tom Schroeder, MS
Statistician
U.S. Consumer Product Safety Commission

Greg Skipper, MD
National Advisory Council Member
Center for Substance Abuse Treatment
Medical Director
Alabama Physician Health Program
Montgomery, AL

Arlene Stanton, PhD, NCC
Social Science Analyst
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

Richard T. Suchinsky, MD
Associate Chief for Addictive Disorders
Department of Veterans Affairs
Washington, DC

Alan Trachtenberg, MD, MPH
Medical Officer
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, MD

Frank J. Vocci, PhD
Director
Division of Treatment Research and Development
National Institute on Drug Abuse
National Institutes of Health
Bethesda, MD

Celia Jaffe Winchell, MD
Medical Team Leader, Addiction Drug Products
Division of Anesthetic, Critical Care, and Addiction Drug Products
Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD